Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

84.61 +0.91 (+1.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,338,318
Open 83.85
Bid (Size) 84.62 (1)
Ask (Size) 85.30 (1)
Prev. Close 83.70
Today's Range 83.41 - 84.63
52wk Range 53.56 - 87.24
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Can Incyte Deliver on 447% EPS Forecasts and Pipeline Hype?
Analysts expect nearly 450% EPS growth in 2025, making execution on its core portfolio critical for sustaining the outperformance experienced so far YTD. 
Via MarketBeat
Incyte Corp (NASDAQ:INCY): A Prime Candidate for Value Investors Seeking Undervalued Stocks
Discover Incyte Corp (INCY), an undervalued biotech stock with strong profitability, solid financial health, and promising growth potential for value investors. 
Via Chartmill

Performance

YTD
+21.7%
+21.7%
1 Month
+13.0%
+13.0%
3 Month
+29.6%
+29.6%
6 Month
+20.4%
+20.4%
1 Year
+28.9%
+28.9%

More News

Read More
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Incyte
Via Business Wire
S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot
Via Benzinga
Topics Stocks
13 Analysts Have This To Say About Incyte
Via Benzinga
Incyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer
From Incyte
Via Business Wire
1 Mid-Cap Stock with Solid Fundamentals and 2 We Find Risky
Via StockStory
2 Mooning Stocks with Exciting Potential and 1 We Ignore
Via StockStory
Barclays Initiates Incyte With Overweight Rating, $90 Price Target, Retail Finds Reason To Cheer
Via Stocktwits
Incyte to Present at Upcoming Investor Conferences
From Incyte
Via Business Wire
Immuno-Oncology Stocks Q2 In Review: Incyte (NASDAQ:INCY) Vs Peers
Via StockStory
Topics Artificial Intelligence
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy Lawsuit
INCY Q2 Deep Dive: Product Launches and Pipeline Progress Underpin Revenue Growth
Via StockStory
1 Momentum Stock for Long-Term Investors and 2 Facing Challenges
Via StockStory
Beyond The Numbers: 12 Analysts Discuss Incyte Stock
Via Benzinga
Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis
From Incyte
Via Business Wire
Incyte Corp (NASDAQ:INCY): A Value Investing Gem with Strong Valuation and Financial Stability
Via Chartmill
Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?
Via Investor's Business Daily
This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday
Via Benzinga
The Analyst Verdict: Incyte In The Eyes Of 10 Experts
Via Benzinga
Top S&P500 movers in Tuesday's session
Via Chartmill
Incyte (INCY) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Incyte Surges Past Expectations With Strong Q2, Boosts Guidance On Jakafi Demand
Via Benzinga
AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday?
Via Benzinga

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 84.61
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 08/29/25 04:00 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 18.82B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.